| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2009-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d79bf684d192bc71f5daf9c8b031c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2381653c27732b6affecf210e8b2bf8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e053c1391de245d0b621b12c2e1ede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5870c68e1103c0c39dac543e6c771a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a760c4ab0335924337dccd17954c109b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b600cad4f8ed49d625676dc86aa06fbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e66dbb614ef50a5ace7d519fa8690d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df75c86b331494a8ceca59ff99b8bd9 |
| publicationDate |
2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2720849-A1 |
| titleOfInvention |
High density compositions containing posaconazole and formulations comprising the same |
| abstract |
The present application provides novel compositions comprising posaconazole and a polymer wherein the compo-sition has a glass transition temperature temperature (Tg) of less than about 1100C. The application also describes compositions comprising posaconazole and a polymer having a bulk density of greater than about 0.4 mg/mL. The application also describes compositions comprising posaconazole and a polymer which provide an exposure (AUCtf) of at least about 10,000 ng.hr/mL when administered to a patient in a fasted state. The application also describes a novel process for preparing these compositions. The preff erred polymer is HPMCAS. Preferably the composition is an extruded material. |
| priorityDate |
2008-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |